Abstract:Despite affecting nearly 80% of menopausal women, the etiology of vasomotor symptoms (VMS) remains unknown. The neuroendocrine circuit associated with the reproductive axis has undergone significant changes after menopause. Many studies have shown that the absence of negative feedback of steroid hormones which synthesized in postmenopausal ovary causes changes in neuropeptide gene expression and kisspeptin/neurokinin B/dynorphin (KNDy) neurons morphology in the hypothalamus of women. Therefore, it is possible that KNDy neurons have an important influence on the mechanism of VMS. In the rat models, the ablation of KNDy neurons can reduce the cutaneous vasodilation of the rat’s tail and partially block the effects of estrogen on thermoregulation. In addition, KNDy neurons can modulate the cutaneous vasodilation of rats through neurokinin B (NKB) signaling in the median preoptic nucleus (MnPO). These studies suggest that the regulation of KNDy neurons may be a promising treatment for VMS. In this paper, we review the possibility of regulating kndy neurons as a new therapy for VMS.